Literature DB >> 5362694

Effect of weight reduction, triiodothyronine, and diethylstilbestrol on growth hormone in obesity.

H J Londono, T F Gallagher, G A Bray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5362694     DOI： 10.1016/0026-0495(69)90014-6

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  6 in total

1.  Nocturnal growth hormone secretion in acromegaly and obesity without electroencephalographic monitoring.

Authors:  R B Mims; R J Lopez
Journal:  J Natl Med Assoc       Date:  1976-05       Impact factor: 1.798

2.  The influence of chronic administration of the serotonin agonist dexfenfluramine on responsiveness to corticotropin releasing hormone and growth hormone-releasing hormone in moderately obese people.

Authors:  M L Drent; H J Adèr; E A van der Veen
Journal:  J Endocrinol Invest       Date:  1995-11       Impact factor: 4.256

3.  Impaired growth hormone secretion in the adult population: relation to age and adiposity.

Authors:  D Rudman; M H Kutner; C M Rogers; M F Lubin; G A Fleming; R P Bain
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

Review 4.  Changing concepts on the control of growth hormone secretion in man.

Authors:  W P VanderLaan
Journal:  Calif Med       Date:  1971-08

5.  Hormones and obesity: changes in insulin and growth hormone secretion following surgically induced weight loss.

Authors:  P M Crockford; P A Salmon
Journal:  Can Med Assoc J       Date:  1970-07-18       Impact factor: 8.262

6.  Impaired prolactin secretion in obese patients.

Authors:  F Cavagnini; C Maraschini; M Pinto; A Dubini; E E Polli
Journal:  J Endocrinol Invest       Date:  1981 Apr-Jun       Impact factor: 4.256
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.